The login/sign up screen for a Twitter account is seen on a laptop computer Tuesday, April 27, 2021, in Orlando, Fla. Twitter is rolling out a subscription service, starting in Canada and Australia, that offers perks like an undo button for subscribers. (AP Photo/John Raoux)
Twitter is rolling out a subscription service, starting in Canada and Australia, that offers perks like an undo button for subscribers.
The “Twitter Blue” subscription service will offer features that users have long asked for — but still no edit button. It includes bookmark folders for organizing saved content; an “Undo tweet" feature that gives users 30 seconds to cancel a sent tweet before it appears; a “reader mode" that makes threaded tweets easier to read; and customizable app icons and color themes.
Subscribers will also get dedicated customer support, meaning issues they report could get attention faster than other users.
The subscription costs 3.50 Canadian dollars ($2.89) a month and 4.50 Australian dollars ($3.45). There's no timeline for rolling out the service in other countries.
Twitter has been adding new features to attract new users. The social media site has nearly 200 million daily users, fewer than other social media networks. Facebook had 1.88 billion daily users on average in March 2021. Snapchat, meanwhile, had 280 million average daily active users in the first quarter.
Twitter shares closed Thursday down 15 cents at $57.01.
Featherie, a line of sustainable and functional golf wear for girls, fills a void in the market, catering to the increasing number of female junior golfers.
The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!
Nvidia did a record $26 billion in sales in the latest quarter. And get ready for the stock to keep climbing, because the A.I. boom is just getting started.
In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d